LOG IN OR SIGN UP TO "MY Eu2P"MEDICINES AND PUBLIC HEALTH
HEALTH CARE RECORDS FROM LARGE DATABASES AS A TOOL TO STUDY THE USE OF MEDICINES
Be ready to discuss the advantages and disadvantages of large databases to avoid and interpret mistakes in health care records
INTEGRATING PHARMACOVIGILANCE AND CONSUMPTION DATA ANALYSIS - USES, LIMITATIONS AND POTENTIALITY
Get a clear idea of the potential utility of drug consumption variables in pharmacovigilance
FROM INDIVIDUAL CASES TO THE COMMUNITY IMPACT OF ADVERSE DRUG REACTIONS: MEASURING TOOLS
Be ready to analyze the population impact of an adverse drug reaction of interestKnow all about the biases, misinterpretations and limitations of the extrapolation of individual risk data to a population
FROM INDIVIDUAL CASES TO THE COMMUNITY IMPACT OF ADVERSE DRUG REACTIONS: LIMITATIONS
Know all about the biases, misinterpretations and limitations of the extrapolation of individual risk data to a population
RISK MANAGEMENT PLANS: THE VALUE OF CONCOMITANT MEDICATION
Have a clear view of the most frequent medicines concomitantly used with the product of interest in risk management plans
RISK MANAGEMENT PLANS: THE EFFECTS OF INAPPROPRIATE USE OF THE TARGET MEDICINE
Know in details the extension and circumstances of the inappropriate use of a medicine of interest
INTERPRETATION OF DRUG CONSUMPTION DATA - USES AND LIMITATIONS IN COMMON PRACTICE
Get a clear picture of the best sources and how to interpret the drug consumption data
IDENTIFICATION OF DISPENSABLE AND REDUNDANT MEDICATION IN THE POPULATION
Identify and reduce dispensable and redundant medication in real clinical practice
BONE FRACTURE ASSOCIATED WITH COMMON MEDICATION - AN EXAMPLE OF THE PUBLIC HEALTH IMPACT ESTIMATION
Assess the public health impact of a combination of adverse effects associated with commonly co-prescribed medicines
INTRACRANIAL BLEEDING ASSOCIATED TO MEDICINES - FROM SYSTEMATIC REVIEWS AND META-ANALYSES TO CONSUMPTION DATABASES
Estimate the contribution of the concomitant use of medicines to the incidence and prevalence of a severe adverse effect
